NeoGenomics (NEO) Tops Q2 EPS by 1c

NeoGenomics (NASDAQ: NEO) reported Q2 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $63.1 million versus the consensus estimate of $61.07 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Tesla Q2 deliveries: What to expect from the critical report
• Doximity downgraded by BofA on AI investment concerns, margin pressure